Kodu・Aktsiate loetelu・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Avatud

SektorTervishoid

95.59 -0.94

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

94.16

Max

96.98

Põhinäitajad
By Trading Economics
Sissetulek	99M 239M
Müük	-157M 2.1B
P/E Sektori keskmine	23.852 64.641
Aktsiakasum	2.09
Dividenditootlus	1.05
Kasumimarginaal	11.43
Töötajad	17,000
EBITDA	84M 538M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+2.66% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	1.05% 2.31%
Järgmine tulemuste avaldamine	5. aug 2026
Järgmine dividendimakse kuupäev	30. okt 2026
Järgmine aktsia dividendi kuupäev (ex-date)	29. sept 2026

Turustatistika
By TradingEconomics
Turukapital	-110M 18B
Eelmine avamishind	96.53
Eelmine sulgemishind	95.59

Uudiste sentiment

By Acuity

31%

69%

97 / 340 Pingereas Healthcare

Zimmer Biomet Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. aug 2026, 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31. juuli 2026, 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30. juuli 2026, 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29. juuli 2026, 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28. juuli 2026, 20:03 UTC

News

Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27. juuli 2026, 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24. juuli 2026, 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23. juuli 2026, 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22. juuli 2026, 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20. juuli 2026, 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Võrdlus sarnastega

Hinnamuutus

Zimmer Biomet Holdings Inc Prognoos

Hinnasiht

By TipRanks

2.66% tõus

12 kuu keskmine prognoos

Keskmine 99.56 USD 2.66%

Kõrge 115 USD

Madal 83 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Zimmer Biomet Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

Osta

Hoia

Müü

Põhineb 10 analüütiku instrumendi Zimmer Biomet Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

97 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.